Skip to main content
. 2019 Nov 26;5(11):e02818. doi: 10.1016/j.heliyon.2019.e02818

Fig. 2.

Fig. 2

Generation of CAR-T Cells for Brain Tumor: T cells are taken from patient's blood and engineered aiming to include a viral vector expressing the chimeric antigen receptor (CAR). After the expansion in culture, CAR-T cells are infused into the same patient. Into the body, the engineered T cells selectively bind neoplastic cells inducing apoptosis.